PDF-read only
Correspondence
Published on 15 Jun 2022
Refractory myositis in a patient of Sjögren’s syndrome having only anti‐SS‐A (60 kDa) antibody
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12218
Type at least 3 characters
376 articles
Articles
PDF-read only
Correspondence
Published on 15 Jun 2022
Linear lichen planus in the lines of Blaschko suggestive of immune‐related adverse event
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12222
PDF-read only
Correspondence
Published on 15 Jun 2022
Efficacy of topical adapalene monotherapy for symptomatic relief in a long‐standing vulvar syringoma: A case report and literature review with treatment update
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12216
PDF-read only
Correspondence
Published on 15 Jun 2022
Unilateral lymphadenopathy associated with COVID‐19 vaccination
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12217
PDF-read only
Correspondence
Published on 15 Jun 2022
Expression of histidine decarboxylase in sweat glands of patients with atopic dermatitis
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12223
PDF-read only
Correspondence
Published on 01 Apr 2022
Postpartum polymorphic eruption of pregnancy prominently occurring on striae distensae
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12204
PDF-read only
Other
Published on 01 Apr 2022
Issue Information
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12182
PDF-read only
Correspondence
Published on 01 Apr 2022
Paraphenylenediamine ingredient possibly contributes to granuloma formation in inflammatory tattoo
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12214
PDF-read only
Correspondence
Published on 01 Apr 2022
Macular‐type cutaneous adverse reaction due to atezolizumab and pembrolizumab
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12206
PDF-read only
Case Study
Published on 01 Apr 2022
Linear childhood discoid lupus erythematosus along a Blaschko's line of the arm
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12221
PDF-read only
Original Research
Published on 01 Apr 2022
Retrospective survey for clinical course and aggravating factors of adolescent atopic dermatitis in two years' cohort study on first‐year university students
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12226
PDF-read only
Original Research
Published on 01 Apr 2022
Clinical effect of delgocitinib 0.5% ointment on atopic dermatitis eczema intensity and skin barrier function
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12213
PDF-read only
Correspondence
Published on 01 Apr 2022
Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12212
PDF-read only
Correspondence
Published on 01 Apr 2022
Sarilumab‐induced cutaneous adverse event
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12208
PDF-read only
Correspondence
Published on 01 Apr 2022
Dupilumab in atopic dermatitis patients with chronic hepatitis B
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12209
PDF-read only
Other
Published on 02 Feb 2022
Issue Information
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12181